Join to View Full Profile
200 Medical Plaza, Suite B265Los Angeles, CA 90095
Phone+1 310-825-9771
Fax+1 310-825-9771
Dr. Kishan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2013 - 2017
Scripps Mercy HospitalInternship, Transitional Year, 2012 - 2013
Harvard Medical SchoolClass of 2012
Certifications & Licensure
CA State Medical License 2014 - 2026
American Board of Radiology Radiation Oncology
Clinical Trials
- Stereotactic Body Radiation Therapy in Treating Patients with Localized Prostate Cancer That Have Undergone Surgery Start of enrollment: 2019 Jan 29
Publications & Presentations
PubMed
- Future directions in the evaluation and management of newly diagnosed metastatic cancer.Eric J Lehrer, Chachrit Khunsriraksakul, Sara Garrett, Daniel M Trifiletti, Jason P Sheehan
Critical Reviews in Oncology/hematology. 2025-04-01 - Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium.Amar U Kishan, Yilun Sun, Alison C Tree, Emma Hall, David Dearnaley
The Lancet. Oncology. 2025-04-01 - The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care.Vedang Murthy, Giulia Marvaso, Barbara A Jereczek-Fossa, Stephanie A Thoma, Marco Vogel
European Urology. 2025-04-01
Journal Articles
- Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized,...James B Yu, Amar U Kishan, JAMA Network Open
Press Mentions
New Test Identifies Prostate Cancer Patients at Risk for Long-Term Radiation Therapy Side EffectsApril 7th, 2025- Similar Efficacy Seen for Isodose, Dose-Escalated MHFRT, CFRT in Prostate CancerApril 2nd, 2025
- Prostate Cancer Radiotherapy Timeline Can Be Safely ShortenedMarch 19th, 2025
- Join now to see all
Grant Support
- Reducing toxicity from prostate cancer radiotherapy through genetics and technologyUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
